Reza Zadno - Mar 3, 2025 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
President, CEO, Director
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Reza Zadno, Ph.D.
Stock symbol
PRCT
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/5/2025, 05:30 PM
Previous filing
Dec 6, 2024
Next filing
Mar 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Award $0 +41.7K +27.3% $0.00 194K Mar 3, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Award $0 +36.8K $0.00 36.8K Mar 3, 2025 Common Stock 36.8K $60.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.
F2 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.